Clinical Trials Browser

Interventional × Neoplasm Metastasis × devimistat × Clear all

Lymphoma, Neoplasm Metastasis, Neoplasms, Recurrence

NCT01832857 2016-12-29

Phase 2 Safety, Tolerability and Efficacy Study of CPI-613 in Cancer Patients

Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Neoplasm Metastasis, Neoplasms, Stomach Neoplasms

NCT01830322 2013-08-14

Safety and Effectiveness Study of CPI-613 and/or Gemcitabine to Treat Metastatic Pancreatic Cancer

Phase 2 Withdrawn

Tumor-Agnostic

Adenocarcinoma, Neoplasm Metastasis, Neoplasms

Clinical Trials

A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies

Phase 2 Safety, Tolerability and Efficacy Study of CPI-613 in Cancer Patients

Safety and Effectiveness Study of CPI-613 and/or Gemcitabine to Treat Metastatic Pancreatic Cancer